Brent Sabatini, SVP, Chief Accounting Officer at Vir Biotechnology, Inc. (VIR), sold 1,562 shares at $9.15 ($14K) on 2025-02-13, disclosed to the SEC on 2025-02-14.
Open-market sale of $14k VIR by SVP, Chief Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| VIR | SELL | 2026-02-26 | $14K | — | Filing → |
| VIR | SELL | 2026-02-24 | $14K | — | Filing → |
| VIR | SELL | 2026-02-18 | $12K | — | Filing → |